2nd Quarter - Report

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS for AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

Firm
Client
Income
—
Expenses
$60,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

In support of the Ensuring Lasting Smiles Act (S 754/HR 1916) In support of the DOC Access Act (HR 3461/S 1793) Concerns regarding implementation of the No Surprises Act and related Interim Final Rules

LobbyistCovered position, as disclosed
DANIELLE A. BRANCH —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
SRINIVASAN VARADARAJAN —
KARIN WITTICH —

Contacted: SENATE; Treasury, Dept of; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL)

Bills named: H.R. 3461 (117th), H.R. 1916 (117th)

Education EDU

Support for legislation to provide interest free deferment for physician and dental residents (HR 4122/S 3658)

LobbyistCovered position, as disclosed
DANIELLE A. BRANCH —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
SRINIVASAN VARADARAJAN —
KARIN WITTICH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4122 (117th)

Alcohol and Drug Abuse ALC

-Prescription drug abuse prevention - sharing the association's efforts to educate our members. - Discussed efforts to modify the MATE Act (HR 2067/S 2235) with House and Senate staff. - Comments to the CDC regarding their draft updated opioid prescribing guideline. - Comments to the FDA regarding a proposal to require industry provide patients filling a controlled substance with mail back envelopes.

LobbyistCovered position, as disclosed
DANIELLE A. BRANCH —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
SRINIVASAN VARADARAJAN —
KARIN WITTICH —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2067 (117th)

Medicare/Medicaid MMM

Support for reforms to the Medicare system to resolve deficiencies in the Medicare physician fee schedule, including addressing the budget neutrality requirement which can lead to arbitrary reductions to reimbursement unrelated to the cost of providing care. Opposition to dental benefits expansion under Medicare Part B Support for Medicaid Dental Benefit Act (H.R. 4439/S 3166)to provide comprehensive and consistent adult dental Medicaid benefits across the country for those who cannot otherwise afford oral healthcare. Support for legislative (HR 5110) and regulatory efforts that would provide Medicare Part B coverage for medically necessary dental treatment. Support for regulatory efforts to develop a coding structure to allow hospitals and ASCs to be sufficiently paid for allowing for dental procedures that take place in their facilities.

LobbyistCovered position, as disclosed
DANIELLE A. BRANCH —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
SRINIVASAN VARADARAJAN —
KARIN WITTICH —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5110 (117th), H.R. 4439 (117th)

Health Issues HCR

- Support for H.R.4555, the Oral Health Literacy and Awareness Act. This bipartisan bill would authorize the Health Resources and Services Administration (HRSA) to implement an evidence-based education campaign to promote oral health literacy among vulnerable populations over a five-year period. - Support for the PREVENT Pandemics Act (S 3799) that would address a number of drug and supply shortages - Support for HR 675 that would empower Attorneys General and their relevant agencies to go after unscrupulous vendors who price gouge during critical events such as national pandemics - Support for S 2595 that would provide grants to manufacturers of critical drugs such as sterile injectables to invest in quality management and ensure extensive and consistent availability of such drugs.

LobbyistCovered position, as disclosed
DANIELLE A. BRANCH —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
SRINIVASAN VARADARAJAN —
KARIN WITTICH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 675 (117th), H.R. 4555 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.